[METRIC]
A-A-51971A
18 December 1992
SUPERSEDING
A-A-0051971 (DM)
11 May 1987
COMMERCIAL ITEM DESCRIPTION
BROMPHENIRAMINE MALEATE AND PHENYLPROPANOLAMINE
HYDROCHLORIDE TABLETS, EXTENDED RELEASE
The General Services Administration has authorized the use of this Commercial Item Description.
Salient characteristics.
Shall be extended-release Brompheniramine Maleate and Phenylpropanolamine Tablets.
Shall be in accordance with the requirements of the FDA.
All ingredients used in the manufacture of the tablets shall be of a pharmaceutical grade.
Shall contain 12 mg of Brompheniramine Maleate and 75 mg of Phenylpropanolamine Hydrochloride per tablet within the applicable assay limits for the tablets.
Workmanship. The tablets shall be free from defects which detract from their appearance or impair their serviceability.
Unit.
For Size 1 – Bottle (BT). One bottle containing 500 tablets, as specified, constitutes one unit.
For Size 2 – Package (PG). Shall be supplied 60 tablets in a commercially available bottle. Bottle shall be supplied with a child-resistant safety closure and shall have a minimum height of 51 mm, base to shoulder. One package containing 24 bottles, as specified, constitutes one unit.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business